Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,774 | 2,021 | 1,179 | 982 | 813 |
| Receivables | 2,204 | 375 | 1,491 | 1,235 | 938 |
| Inventories | 2,216 | 2,379 | 2,739 | 3,134 | 3,453 |
| TOTAL | $7,418 | $6,289 | $6,382 | $6,586 | $6,448 |
| Non-Current Assets | |||||
| PPE Net | 72 | 75 | 79 | 85 | 138 |
| Investments And Advances | 38,533 | 38,799 | 32,537 | 35,972 | 41,292 |
| Other Non-Current Assets | 2,923 | 3,062 | 3,203 | 3,346 | 3,615 |
| TOTAL | $41,528 | $41,936 | $35,819 | $39,403 | $45,045 |
| Total Assets | $48,946 | $48,225 | $42,201 | $45,989 | $51,493 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 3,248 | 4,672 | 8,522 | 400 |
| Accounts payable and accrued liabilities | 14,423 | 13,549 | 11,134 | 10,718 | 9,718 |
| Other current liabilities | 14,057 | 12,987 | 2,303 | 2,791 | 3,577 |
| TOTAL | $57,855 | $54,323 | $41,523 | $46,076 | $34,551 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,426 | 380 | 3,381 | N/A | 1,500 |
| Other Non-Current Liabilities | 23,618 | 27,613 | 34,886 | 34,548 | 37,741 |
| TOTAL | $27,044 | $27,993 | $38,267 | $34,548 | $39,241 |
| Total Liabilities | $84,899 | $82,316 | $79,790 | $80,624 | $73,792 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,638 | 50,935 | 49,559 | 49,559 | 49,312 |
| Common Shares | 51 | 50 | 50 | 50 | 49 |
| Retained earnings | -255,905 | -252,337 | -252,537 | -252,146 | -242,808 |
| Other shareholders' equity | -2,977 | -2,619 | -5,905 | -3,339 | 433 |
| TOTAL | $-35,953 | $-34,091 | $-37,589 | $-34,635 | $-22,299 |
| Total Liabilities And Equity | $48,946 | $48,225 | $42,201 | $45,989 | $51,493 |